Product Information
BRIVIACT 25 MG TABLET is a brand product labeled by UCB, Inc., priced at $24.0660 per EA under NDC 50474047066. Its NADAC has been published 362 times since Sep 18, 2019.
FDA first approved this application on May 12, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25 mg/1
Manufacturer
UCB, Inc.NDC
50474047066
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
BRIVARACETAMApproval Type
New Drug (NDA)
FDA Application
NDA205836FDA Approved
5/12/2016
TE Code
AB
On Market Since
5/12/2016
Pharmacological Classes
Price Statistics
The NADAC for BRIVIACT 25 MG TABLET has been published 362 times since Sep 18, 2019, and over the history we have for it it has risen 31.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $24.0660 per EA |
|---|---|
| All-time high | $24.0782 (Jun 10, 2026) |
| All-time low | $18.3614 (Sep 18, 2019) |
| 52-week high | $24.0782 |
| 52-week low | $23.4274 |
| Median price | $21.8044 |
| Average price | $21.3355 |
| Largest weekly change | +6.9% (Jan 12, 2022) |
| Weeks tracked | 362 |
| Tracking since | Sep 18, 2019 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BRIVIACT 25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BRIVIACT 25 MG TABLET, manufactured by UCB, Inc., is $24.0660 per EA (NDC 50474047066), effective Aug 19, 2026.
How has the price of BRIVIACT 25 MG TABLET changed over time?
Over the history we have for it, the NADAC for BRIVIACT 25 MG TABLET has risen 31.1%. It has been tracked across 362 weekly CMS publications since Sep 18, 2019.
What are the highest and lowest recorded NADAC prices for BRIVIACT 25 MG TABLET?
Since Sep 18, 2019, the NADAC for BRIVIACT 25 MG TABLET has ranged from a low of $18.3614 (Sep 18, 2019) to a high of $24.0782 (Jun 10, 2026), with a median of $21.8044 per EA.
Are there cheaper alternatives to BRIVIACT 25 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as BRIVIACT 25 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures BRIVIACT 25 MG TABLET?
BRIVIACT 25 MG TABLET (NDC 50474047066) is labeled by UCB, Inc., and CMS classifies it as a brand product.